Navigate Fool.com
Will MSTX beat
the market?

Mast Therapeutics, Inc.


Community Rating: 3 Stars: Appealing

0.56 0.01 (1.80%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.55
Previous Close $0.55
Daily Range $0.54 - $0.58
52-Week Range $0.40 - $1.10
Market Cap $63.6M
P/E Ratio -2.00
Dividend (Yield) $0.00 (0.0%)
Volume 934,008
Average Daily Volume 2,704,675
Current FY EPS -$0.29

How do you think MSTX
will perform against the market?

Top MSTX Bull/Bear Pitches


TSIF (< 20)
Submitted November 17, 2011

I caught Adventrx Pharmaceuticals, Inc plunging like a rock on November 11th and I stopped in to see if my favorite CAPS bio followers had rated it. ZZlangerhans had just given it one of his speculat … More

4 Replies Reply Report this Post

zzlangerhans (< 20)
Submitted June 28, 2011

I reached out to Adventrx about a year ago, seeing multibagger Bottle Imp potential based on their early 2010 performance after the initial Exelbine NDA submission. I gave up on the pick two months ag … More

0 Replies Reply Report this Post

News & Commentary

The Big Bet on YM BioSciences

Playing catch-up in myelofibrosis.

Four Biotech Names with Major Market Potential: Michael Higgins

ADVENTRX Files To Raise Capital (ANX)

Zacks #1 Rank Additions for Monday - Tale of the Tape

Blue Horseshoe - Or Someone - Likes Anaconda Mining; Shares Pop 20% After Selling Iron Ore Assets

Zacks #1 Rank Additions for Friday - Tale of the Tape

Zacks #1 Rank Additions for Friday - Tale of the Tape

Speedy in Seattle

Seattle Genetics gets an early approval of Adcentris.

5 of Last Week's Biggest Losers

These five stocks made shorts a lot of money last week.

Aeterna Zentaris: Out of Sight, Out of Mind

Perifosine, the company's lead cancer drug, hits key milestones.

Adventrx Plunges Almost 60% on Botched Drug Study

CEO Culley says the company's lead drug candidate, Exelbine for lung cancer, may be sold.

See More MSTX News...





Mast Therapeutics, Inc. (MSTX) Description

A biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases. Website: http://www.masttherapeutics.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks